EA201291281A1 - Производные хинолизидина и индолизидина - Google Patents
Производные хинолизидина и индолизидинаInfo
- Publication number
- EA201291281A1 EA201291281A1 EA201291281A EA201291281A EA201291281A1 EA 201291281 A1 EA201291281 A1 EA 201291281A1 EA 201291281 A EA201291281 A EA 201291281A EA 201291281 A EA201291281 A EA 201291281A EA 201291281 A1 EA201291281 A1 EA 201291281A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- glyt
- general formula
- lower alkyl
- inhibitors
- glycine transporter
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
- C07D455/02—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing not further condensed quinolizine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Соединение общей формулы I-А или I-Вгде X представляет собой связь или -СН-группу; R, Rи Rнезависимо друг от друга представляют собой водород, низший алкокси, низший алкил, замещенный галогеном, или S-низший алкил; или его фармацевтически приемлемая соль присоединения кислот, рацемическая смесь или его соответствующий энантиомер и/или оптический изомер. Было обнаружено, что соединения общей формулы I-A и I-B являются хорошими ингибиторами глицинового переносчика 1 (GlyT-1) и что они обладают высокой селективностью в отношении ингибиторов глицинового переносчика 2 (GlyT-2), что делает их приемлемыми для применения при лечении неврологических и нервно-психических расстройств.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP10166776 | 2010-06-22 | ||
| PCT/EP2011/060077 WO2011161008A1 (en) | 2010-06-22 | 2011-06-17 | Quinolizidine and indolizidine derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EA201291281A1 true EA201291281A1 (ru) | 2013-06-28 |
Family
ID=44314179
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA201291281A EA201291281A1 (ru) | 2010-06-22 | 2011-06-17 | Производные хинолизидина и индолизидина |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US8143273B2 (ru) |
| EP (1) | EP2585460B1 (ru) |
| JP (1) | JP5659299B2 (ru) |
| KR (1) | KR101431949B1 (ru) |
| CN (1) | CN102947301B (ru) |
| AR (1) | AR082766A1 (ru) |
| AU (1) | AU2011269147A1 (ru) |
| BR (1) | BR112012030886A2 (ru) |
| CA (1) | CA2797874C (ru) |
| CL (1) | CL2012003553A1 (ru) |
| CO (1) | CO6630104A2 (ru) |
| CR (1) | CR20120601A (ru) |
| EA (1) | EA201291281A1 (ru) |
| ES (1) | ES2523572T3 (ru) |
| HK (1) | HK1179609A1 (ru) |
| IL (1) | IL222602A0 (ru) |
| MA (1) | MA34250B1 (ru) |
| MX (1) | MX2012013580A (ru) |
| PE (1) | PE20130776A1 (ru) |
| SG (1) | SG186327A1 (ru) |
| TW (1) | TWI412526B (ru) |
| WO (1) | WO2011161008A1 (ru) |
| ZA (1) | ZA201209089B (ru) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014199960A1 (ja) * | 2013-06-10 | 2014-12-18 | 大正製薬株式会社 | グリシントランスポーター阻害物質 |
| KR102380870B1 (ko) | 2019-06-19 | 2022-03-31 | 한양대학교 에리카산학협력단 | 퀴놀리지딘 화합물 및 그 제조방법 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA795318B (en) * | 1978-10-13 | 1980-09-24 | Hoffmann La Roche | Phenyl quinolizidines |
| NZ191763A (en) | 1978-10-13 | 1984-05-31 | Hoffmann La Roche | 7-beta-phenyl-quinolidines, intermediates and pharmaceutical compositions |
| EP0067565A1 (en) * | 1981-06-16 | 1982-12-22 | Beecham Group Plc | Pharmaceutically active compounds |
| JP2004510712A (ja) * | 2000-09-22 | 2004-04-08 | オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド | オクタヒドロ−インドリジンおよびキノリジンおよびヘキサヒドロ−ピロリジン |
| WO2003055856A2 (en) * | 2001-10-17 | 2003-07-10 | Bristol-Myers Squibb Company | BICYCLIC LACTAM DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES AND/OR TNF-α CONVERTING ENZYME (TACE) |
| FR2906251B1 (fr) | 2006-09-22 | 2008-11-07 | Sanofi Aventis Sa | Derives de pyrrolizine, indolizine et quinolizine, leur preparation et leur application en therapeutique |
| US20110306597A1 (en) * | 2008-06-18 | 2011-12-15 | James Michael Crawforth | Nicotinamide Derivatives |
-
2011
- 2011-06-16 US US13/161,534 patent/US8143273B2/en not_active Expired - Fee Related
- 2011-06-17 WO PCT/EP2011/060077 patent/WO2011161008A1/en active Application Filing
- 2011-06-17 MX MX2012013580A patent/MX2012013580A/es active IP Right Grant
- 2011-06-17 EA EA201291281A patent/EA201291281A1/ru unknown
- 2011-06-17 ES ES11726146.1T patent/ES2523572T3/es active Active
- 2011-06-17 AU AU2011269147A patent/AU2011269147A1/en not_active Abandoned
- 2011-06-17 JP JP2013515818A patent/JP5659299B2/ja active Active
- 2011-06-17 KR KR1020127032605A patent/KR101431949B1/ko active IP Right Grant
- 2011-06-17 CA CA2797874A patent/CA2797874C/en not_active Expired - Fee Related
- 2011-06-17 BR BR112012030886A patent/BR112012030886A2/pt not_active IP Right Cessation
- 2011-06-17 EP EP11726146.1A patent/EP2585460B1/en active Active
- 2011-06-17 PE PE2012002454A patent/PE20130776A1/es not_active Application Discontinuation
- 2011-06-17 SG SG2012091682A patent/SG186327A1/en unknown
- 2011-06-17 MA MA35397A patent/MA34250B1/fr unknown
- 2011-06-17 CN CN201180030484.9A patent/CN102947301B/zh active Active
- 2011-06-20 TW TW100121497A patent/TWI412526B/zh not_active IP Right Cessation
- 2011-06-21 AR ARP110102139A patent/AR082766A1/es unknown
-
2012
- 2012-10-10 CO CO12178886A patent/CO6630104A2/es active IP Right Grant
- 2012-10-22 IL IL222602A patent/IL222602A0/en unknown
- 2012-11-28 CR CR20120601A patent/CR20120601A/es unknown
- 2012-11-30 ZA ZA2012/09089A patent/ZA201209089B/en unknown
- 2012-12-17 CL CL2012003553A patent/CL2012003553A1/es unknown
-
2013
- 2013-06-05 HK HK13106614.8A patent/HK1179609A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CN102947301B (zh) | 2015-02-11 |
| SG186327A1 (en) | 2013-01-30 |
| EP2585460A1 (en) | 2013-05-01 |
| EP2585460B1 (en) | 2014-10-01 |
| MX2012013580A (es) | 2013-01-24 |
| CO6630104A2 (es) | 2013-03-01 |
| BR112012030886A2 (pt) | 2016-11-08 |
| WO2011161008A1 (en) | 2011-12-29 |
| CA2797874C (en) | 2018-04-24 |
| MA34250B1 (fr) | 2013-05-02 |
| AU2011269147A1 (en) | 2012-11-01 |
| US8143273B2 (en) | 2012-03-27 |
| CL2012003553A1 (es) | 2013-03-22 |
| TWI412526B (zh) | 2013-10-21 |
| US20110313165A1 (en) | 2011-12-22 |
| CR20120601A (es) | 2013-01-03 |
| IL222602A0 (en) | 2012-12-31 |
| JP2013529609A (ja) | 2013-07-22 |
| KR20130028756A (ko) | 2013-03-19 |
| CN102947301A (zh) | 2013-02-27 |
| PE20130776A1 (es) | 2013-07-03 |
| ES2523572T3 (es) | 2014-11-27 |
| CA2797874A1 (en) | 2011-12-29 |
| HK1179609A1 (en) | 2013-10-04 |
| KR101431949B1 (ko) | 2014-08-19 |
| ZA201209089B (en) | 2013-08-28 |
| AR082766A1 (es) | 2013-01-09 |
| JP5659299B2 (ja) | 2015-01-28 |
| TW201206928A (en) | 2012-02-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA35452B1 (fr) | 3-pyrimidin-4-yl-oxazolidin-2-ones comme inhibiteurs d'idh mutante | |
| CY1117773T1 (el) | Νεες χειρικες ν-ακυλ-5,6,7,8-υποκατεστημενες)-τετραϋδρο-[1,2,4]τριαζολο[4,3-a]πυραζινες ως επιλεκτικοι ανταγωνιστες του υποδοχεα νκ-3, φαρμακευτικη συνθεση και μεθοδοι για τη χρηση σε διαταραχες μεσολαβουμενες απο τον υποδοχεα νκ-3 | |
| EA201000805A1 (ru) | Бис-(сульфониламино)производные в терапии 066 | |
| EA201490807A1 (ru) | Новые замещенные имидазопиримидины как модуляторы рецептора gpbar1 | |
| EA201391537A1 (ru) | ЭТИНИЛЬНЫЕ ПРОИЗВОДНЫЕ В КАЧЕСТВЕ ПОЛОЖИТЕЛЬНЫХ АЛЛОСТЕРИЧЕСКИХ МОДУЛЯТОРОВ mGluR5 | |
| AR082154A1 (es) | DERIVADOS DE PIRAZOLO[1,5-a]PIRIMIDINA COMO MODULADORES DE IRAK4 | |
| EA201001013A1 (ru) | Бис(сульфониламино)производные для применения в терапии | |
| EA201300250A1 (ru) | Оксадиазольные ингибиторы продуцирования лейкотриена | |
| RS54183B1 (en) | PIRAZOLE DERIVATIVES | |
| EA200900924A1 (ru) | Циклизованные производные как ингибиторы eg-5 | |
| EA201490722A1 (ru) | ПРОИЗВОДНЫЕ ЭТИНИЛА В КАЧЕСТВЕ АЛЛОСТЕРИЧЕСКИХ МОДУЛЯТОРОВ МЕТАБОТРОПНОГО РЕЦЕПТОРА ГЛУТАМАТА mGluR5 | |
| EA201590438A1 (ru) | 2-оксо-2,3-дигидроиндолы для лечения расстройств центральной нервной системы | |
| EA200901051A1 (ru) | Новый способ разделения энантиомеров (3,4-диметоксибицикло[4.2.0]окта-1,3,5-триен-7-ил)нитрила и применение при синтезе ивабрадина | |
| AR104331A1 (es) | Derivados de tetrazol | |
| UA104611C2 (en) | Aroylamino- and heteroaroylamino-substituted piperidines as glyt-1 inhibitors | |
| EA201391538A1 (ru) | Производные пиразолидин-3-она | |
| EA201291281A1 (ru) | Производные хинолизидина и индолизидина | |
| CR20150158A (es) | Derivados de etinilo como moduladores de receptor de actividad mglur5 | |
| AR077820A1 (es) | Inhibidores de las jnk | |
| PH12015500261A1 (en) | Arylethynyl pyrimidines | |
| EA201070814A1 (ru) | Производные 6-гетероциклоимидазо[1,2-а]пиридин-2-карбоксамидов, их получение и их применение в терапии | |
| PE20150341A1 (es) | Piperazino[1,2-a]indol-1-onas y [1,4]diazepino[1,2-a]indol-1-ona | |
| EA201490720A1 (ru) | Этинильные производные в качестве модуляторов метаботропного глутаматного рецептора | |
| EA201291374A1 (ru) | Производные амидотропана | |
| ECSP12012356A (es) | Derivados de quinolizidina e indolizidina |